Literature DB >> 32341443

Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients.

Andrea Dalbeni1, Alessandro Giollo2, Michele Bevilacqua3, Giovanni Cioffi2, Angela Tagetti3, Filippo Cattazzo3, Giovanni Orsolini2, Federica Ognibeni2, Pietro Minuz3, Maurizio Rossini2, Cristiano Fava3, Ombretta Viapiana2.   

Abstract

Patients with rheumatoid arthritis (RA) have an increased incidence of cardiovascular events. Ultrasound examination of the carotid arteries can show the presence of plaques and detect the atherosclerotic subclinical process through the evaluation of intima-media thickness (cIMT) and carotid segmental distensibility (cCD). The aim of the present study was to identify which factors could independently influence the evolution of atherosclerosis (plaques, cIMT, and cCD) after 1 year of follow-up in a sample of patients with RA. A total of 137 patients with RA without previous cardiovascular (CV) events were enrolled at baseline, and 105 (M/F: 21/84, age 59.34 ± 11.65 years) were reassessed after one year using ultrasound of carotid arteries to detect atheromatous plaques and to measure cIMT and cCD. After one year, all the indices of subclinical atherosclerosis worsened with respect to baseline (Δ-cIMT = 0.030 ± 0.10 mm, p = 0.005; Δ-cCD = -1.64 ± 4.83, 10-3/KPa, p = 0.005; Δ-plaques = 8.6%, p = 0.035). Traditional CV risk factors (age, mean arterial pressure, and diabetes) and corticosteroid therapy were independently associated with the worsening of subclinical atherosclerosis. Interestingly, when considering RA patients divided according to the degree of disease activity score 28 with C-reactive protein (DAS28 [CRP] ≥2.6), the worsening of subclinical atherosclerosis indices was detectable exclusively in the group of patients with active disease. Our longitudinal study supports the hypothesis of a key role of both traditional CV risk factors and the inflammatory activity of arthritic disease in the progression of subclinical atherosclerosis in RA patients. In addition, corticosteroids might have a deleterious effect.

Entities:  

Keywords:  Residual disease activity; Rheumatoid arthritis; Subclinical atherosclerosis; Traditional cardiovascular risk factors

Year:  2020        PMID: 32341443     DOI: 10.1038/s41440-020-0441-1

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  4 in total

1.  Association of atherogenic indices with C-reactive protein and risk factors to assess cardiovascular risk in rheumatoid arthritis patient at Tikur Anbessa Specialized Hospital, Addis Ababa.

Authors:  Gashaw Dessie
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

Review 2.  Macrophage Dysfunction in Autoimmune Rheumatic Diseases and Atherosclerosis.

Authors:  Elena V Gerasimova; Tatiana V Popkova; Daria A Gerasimova; Tatiana V Kirichenko
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

3.  Do individuals with autoimmune disease have increased risk of subclinical carotid atherosclerosis and stiffness?

Authors:  Maria Del Mar Vila; Beatriz Remeseiro; Laura Igual; Roberto Elosua; Rafel Ramos; Jose Manuel Valdivielso; Ruth Martí-Lluch; Jaume Marrugat; Maria Grau
Journal:  Hypertens Res       Date:  2021-04-08       Impact factor: 3.872

4.  Patterns of multimorbidity and their effects on adverse outcomes in rheumatoid arthritis: a study of 5658 UK Biobank participants.

Authors:  Frances S Mair; Stefan Siebert; Ross McQueenie; Barbara I Nicholl; Bhautesh D Jani; Jordan Canning; Sara Macdonald; Colin McCowan; Joanne Neary; Susan Browne
Journal:  BMJ Open       Date:  2020-11-23       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.